简体中文 | 繁體中文 | English

Products & Services News

2023-02-23 16:36 CSG and Axiata Digital Labs Bolster Partnership with Joint Customer in Namibia
2023-02-23 14:57 Ferrer Acquires Worldwide Rights to ASN90, an O-GlcNAcase Inhibitor From Asceneuron, Exclusively to Treat Progressive Supranuclear Palsy (PSP)
2023-02-23 14:44 Sinovac Amends Shareholder Rights Plan
2023-02-23 09:39 LevitasBio Launches LeviSelect Suite of Cell Depletion & Enrichment Kits
2023-02-23 09:31 Gallium Semiconductor Unveils Cutting-Edge Manufacturing Facility in the Philippines
2023-02-23 09:05 Shenzhen International Marathon Concludes Safe with Hytera Push-to-Talk Solution
2023-02-22 18:44 Hume Bank Transforms Customer Onboarding with Q2’s Cloud-based Loan Origination Platform
2023-02-22 18:41 FINEOS and Empathy Partner to Bring Complete Support to Life Insurance Beneficiaries
2023-02-22 18:37 Mavenir and Hewlett Packard Enterprise Expand Collaboration on Open vRAN solutions
2023-02-22 16:02 Marlink to Drive Digital Transformation Across French Guiana Leveraging SES’s Multi-Orbit Satellite Network
2023-02-22 15:41 New Study Evaluates the Utility of Masimo ORi™ in Reducing Hyperoxemia During Laparoscopic Gastrectomy
2023-02-22 09:51 Wemade Updates the Highest Floors of Magic Square and Secret Peak in MIR4!
2023-02-22 09:45 Introducing Starbucks Oleato™ – a Revolutionary New Coffee Ritual
2023-02-21 18:47 Smiths Detection awarded contract to upgrade New Zealand’s airport checkpoint security
2023-02-21 18:11 Leading fashion company joins fiber-to-fiber consortium founded by Carbios, On, Patagonia, PUMA and Salomon
2023-02-21 13:34 HKSTP Kicks off “Talent Game On 2K23” Programme to Usher a Golden Era of Innovation & Technology
2023-02-21 10:57 Biocytogen Launches “Nano 100 Project” to Develop Fully Human Nanobody Therapeutics for Over 100 Targets
2023-02-21 09:09 GTJAI Launched the Margin Interest Rate Promotion as low as 3.88%, Assisting Clients in Capturing Investment Opportunities in 2023
2023-02-20 09:42 U.S. Companies Subjected to New Activist Campaigns Increased by 10.6% in 2022, According to Diligent
2023-02-20 09:17 Takeda Presents Positive Results from Phase 3 Study of Vedolizumab for Prevention of Intestinal Acute Graft-Versus-Host Disease (aGvHD) in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)

Business Wire Weibo

Press Releases

Latest Releases